Table 4 Distribution of disease etiology among new hepatocellular carcinoma cases in each quarter.
From: Trends in hepatocellular carcinoma incident cases in Japan between 1996 and 2019
Etiology | First quarter (1996–2001) n = 4311 | Second quarter (2002–2007) n = 5505 | Third quarter (2008–2013) n = 5776 | Fourth quarter (2014–2019) n = 4955 |
|---|---|---|---|---|
HBV n = 2997 (14.6%) | 579 (13.4%) | 853 (15.5%) | 889 (15.4%) | 676 (13.7%) |
HBV + HCV n = 187 (0.9%) | 67 (1.6%) | 65 (1.2%) | 39 (0.7%) | 16 (0.3%) |
HCV n = 12,019 (58.5%) | 3147 (73.0%) | 3636 (66.0%) | 3233 (56.0%) | 2003 (40.4%) |
Non-BC n = 5344 (26.0%) | 518 (12.0%) | 951 (17.3%) | 1615 (27.9%) | 2260 (45.6%) |
P-value | - | P < 0.0001 (vs. First quarter) | P < 0.0001 (vs. Second quarter) | P < 0.0001 (vs. Third quarter) |
